Oregon Bio invites You to be the change
System racial and ethnic disparities are not only a societal problem, but also a health problem. Inequities affect the patients and customers we serve. Do our bio-business priorities advance diversity in attracting and retaining talent, in populating clinical trials, in updating supply chain relationships and in delivery of healthcare to underrepresented populations? How can our local biosicence industry move the conversation to improve diversity, equity and inclusion in our world? Can we each be the change? On July 30, join your peers for an important equity conversation through the lens of Oregon’s bio and technology community. Hear/respond to a live panel of local experts who will illuminate discussion and the opportunities and challenges for diversifying our region’s bio science industry. We’re inviting you to join us for a dialogue with our local company and industry experts who can share best practices and insightful conversation. Let’s consider how the bio industry can be a force for change.
- Soundharya Nagasubramanian, Director , R&D , Product Information Security for Hillrom and Oregon Bio Board Member
- Emmanuel Akporiaye, PhD and founder of Veana Therapeutics
- Don Khouma – Principal Validation Engineer, Genentech
- Nate Miles – Vice President of Strategic Initiatives, Government Affairs at Eli Lilly and Company
Preregister HERE for your invitation email.
Sponsor comment: “Amgen has long-valued its commitment to promoting an environment of Diversity, Inclusion and Belonging. The continuing racial injustices against Black people across the country, coupled with a deadly global pandemic that disproportionately affects communities of color, requires swift and persistent action from all of us to create a more equitable environment for Black lives. We are committed to taking such action and are making the continued investments necessary to drive change at Amgen and beyond.” – Edda Colon Irizarry, VP – Human Resources